Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Talk outline
- 1. What are channelopathies?
- 2. Framework for thinking about channelopathies
- Central dogma of molecular biology (extended)
- Relationship between genotype and phenotype
- Example 1 - human beta-globin gene
- Example 2 - P/Q Ca2+ channel gene (CACNA1A)
- Example 3 - CACNA1A roles in different cell types
- Example 4 - Protein modulates other gene product
- Factors governing genotype-phenotype relationship
- The functional link between genotype & phenotype
- 3. Ion channelopathies
- Classification based on clinical disorder
- Classification can be related to channel structure
- Characterization of permeation and gating
- Classification based on permeation and gating
- 4. Voltage-gated Ca2+ channels
- Functional domains of the Ca2+ channel subunits
- Voltage-gated Ca2+ channel alpha1 mutations
- 5. Human P/Q Ca2+ channelopathies
- Episodic Ataxia Type 2 (EA2)
- Human EA2 mutation F1491S
- Familial Hemiplegic Migraine Type 1 (FHM1)
- Human FHM1 mutation R192Q
- Spinocerebellar Ataxia Type 6 (SCA6)
- Ca2+ channel mutations: Cellular level
- Ca2+ channel mutations: Small circuit level
- Mutations vs. Polymorphisms
- Alleles classification is based on their frequency
- Summary
Topics Covered
- Gene mutations viewed in the context of the central dogma of molecular biology
- Relationship between genotype and phenotype and the impact of mutations
- Classification of ion channels and channelopathies
- Structure function relations for voltage-gated Ca2+ channels
- P/Q type Ca2+ channelopathies
- Ca2+ channel mutations and sources of cell- and circuit-level phenotypic diversity
- Distinction between mutations and polymorphisms
Talk Citation
Friel, D. (2012, November 18). Ca2+ channelopathies [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 27, 2024, from https://doi.org/10.69645/QTHC1017.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. David Friel has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.